Karimi-Busheri (2013) [43] further identified the CD24+/CD38− phenotype as a potential biomarker for non-small cell lung cancer, collectively suggesting that CD24 plays a significant role in lung cancer development and progression. The gene discussed is CD24; the disease is lung cancer.